<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01300130</url>
  </required_header>
  <id_info>
    <org_study_id>45-95</org_study_id>
    <nct_id>NCT01300130</nct_id>
  </id_info>
  <brief_title>Investigations on Improving Docosahexaenoic and Arachidonic Acid Content in Preterm Infant Formula</brief_title>
  <official_title>Investigations on Improving Docosahexaenoic and Arachidonic Acid Content in Preterm Infant Formula</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ludwig-Maximilians - University of Munich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Nestlé</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>German Federal Ministry of Education and Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>German Research Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Ludwig-Maximilians - University of Munich</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators examined the effect of different levels of docosahexaenoic aicd (a long
      chain polyunsaturated fatty acid) intake on the fatty acid composition of plasma and
      erythrocyte phospholipids and on the maturity of visually evoked potentials in preterm
      infants. As a secondary outcome the conversion of linoleic acid and alpha linolenic acid into
      their corresponding long chain polyunsaturated fatty acids was studied.

      Preterm infants were randomized in a double-blind fashion to one of three formulas containing
      different amounts of docosahexaenoic acid during the first two weeks of postnatal life. A
      control group received human milk. Blood samples were collected at study entry and 14 and 28
      days thereafter. Uniformly 13C-labeled linoleic acid and alpha linolenic acid were applied
      orally before blood sampling at day 28. At postconceptional ages 48 weeks and 56 weeks
      visually evoked potentials were recorded.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 1995</start_date>
  <completion_date type="Actual">March 1998</completion_date>
  <primary_completion_date type="Actual">March 1998</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>plasma phospholipid fatty acid composition</measure>
    <time_frame>28 days after intervention start</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>visually evoked potentials</measure>
    <time_frame>48 weeks and 56 weeks postconceptional age</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>intensity of endogenous conversion of essential fatty acids into long chain polyunsaturated fatty acids</measure>
    <time_frame>28 days after study start</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">66</enrollment>
  <condition>Prematurity of Fetus</condition>
  <arm_group>
    <arm_group_label>low docosahexaenoic acid formula</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>medium docosahexaenoic acid formula</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>high docosahexaenoic acid formula</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>human milk</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>low docosahexaenoic acid formula</intervention_name>
    <arm_group_label>low docosahexaenoic acid formula</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>medium docosahexaenoic acid formula</intervention_name>
    <arm_group_label>medium docosahexaenoic acid formula</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>high docosahexaenoic acid formula</intervention_name>
    <arm_group_label>high docosahexaenoic acid formula</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>breast milk</intervention_name>
    <description>a non randomized group of breast milk fed infants was included</description>
    <arm_group_label>human milk</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  preterm birth

          -  birth weight between 1000 and 2200 g

          -  more than 80 % of energy intake from infant formula or human milk at enrollment

        Exclusion Criteria:

          -  apparent genetic, gastrointestinal or metabolic disorders

          -  artificial ventilation or oxygen supply &gt; 30% at the time of enrollment

          -  administration of parenteral fat emulsion (&gt; 1 g/kg/day for more than seven days)
             before or after study entry
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>14 Days</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Berthold Koletzko, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ludwig-Maximilians - University of Munich</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Children´s Hospital, Zentralklinikum Augsburg</name>
      <address>
        <city>Augsburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Josephinum Hospital</name>
      <address>
        <city>Augsburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>I. Frauenklinik of the Ludwig-Maximilians-University</name>
      <address>
        <city>München</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lachnerklinik</name>
      <address>
        <city>München</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Rechts der Isar</name>
      <address>
        <city>München</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>February 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 18, 2011</study_first_submitted>
  <study_first_submitted_qc>February 18, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 21, 2011</study_first_posted>
  <last_update_submitted>February 18, 2011</last_update_submitted>
  <last_update_submitted_qc>February 18, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 21, 2011</last_update_posted>
  <responsible_party>
    <name_title>Ludwig-Maximilians - University of Munich</name_title>
    <organization>Ludwig-Maximilians - University of Munich</organization>
  </responsible_party>
  <keyword>neurological development</keyword>
  <keyword>preterm infants</keyword>
  <keyword>fatty acid status</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

